TD Ameritrade Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-22
| Closed | -$2K | – | 550 |
|
|
2023
Q1 | $2K | Hold |
22
| – | – | ﹤0.01% | 468 |
|
|
2022
Q4 | $2K | Sell |
22
-54
| -71% | -$4.91K | ﹤0.01% | 479 |
|
|
2022
Q3 | $6K | Sell |
76
-57
| -43% | -$4.5K | ﹤0.01% | 410 |
|
|
2022
Q2 | $11K | Sell |
133
-18
| -12% | -$1.49K | ﹤0.01% | 425 |
|
|
2022
Q1 | $12K | Buy |
151
+12
| +9% | +$954 | ﹤0.01% | 472 |
|
|
2021
Q4 | $12K | Buy |
139
+95
| +216% | +$8.2K | ﹤0.01% | 465 |
|
|
2021
Q3 | $3K | Sell |
44
-36
| -45% | -$2.46K | ﹤0.01% | 546 |
|
|
2021
Q2 | $7K | Buy |
80
+42
| +111% | +$3.68K | ﹤0.01% | 495 |
|
|
2021
Q1 | $3K | Hold |
38
| – | – | ﹤0.01% | 554 |
|
|
2020
Q4 | $3K | Sell |
38
-6
| -14% | -$474 | ﹤0.01% | 554 |
|
|
2020
Q3 | $3K | Hold |
44
| – | – | ﹤0.01% | 546 |
|
|
2020
Q2 | $5K | Sell |
44
-5
| -10% | -$568 | ﹤0.01% | 506 |
|
|
2020
Q1 | $4K | Sell |
49
-14
| -22% | -$1.14K | ﹤0.01% | 494 |
|
|
2019
Q4 | $5K | Buy |
63
+58
| +1,160% | +$4.6K | ﹤0.01% | 512 |
|
|
2019
Q3 | $0 | Buy |
+5
| New | – | ﹤0.01% | 634 |
|
|
2019
Q1 | – | Sell |
-23
| Closed | -$2K | – | 573 |
|
|
2018
Q4 | $2K | Buy |
23
+11
| +92% | +$957 | ﹤0.01% | 526 |
|
|
2018
Q3 | $1K | Buy |
12
+2
| +20% | +$167 | ﹤0.01% | 525 |
|
|
2018
Q2 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 407 |
|